Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ASND

Recent news which mentions ASND

What 14 Analyst Ratings Have To Say About Ascendis Pharma
Tickers ASND
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Why Ascendis Pharma Stock Is Sinking Today
Tickers ASND
Tags Recent Press Releases ASND Market News
From Motley Fool
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags TMDI IMMP FENC
From Benzinga
BofA Upgrades Ascendis Pharma After Promising TCP Phase 3 Data
Tickers ASND
Tags Analyst Ratings BofA Securities Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022
Tickers AL ASND BIGC BIVI
Tags WAFD XPOF HTLD
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers ASND AVGR CLSD ERYP
Tags NKTR IMAB OPGN
From Benzinga
10 Biggest Price Target Changes For Monday
Tickers ASND AVDX COCO GIII
Tags Pre/Market Outlook MTN Analyst Ratings
From Benzinga
Ascendis Pharma's Hypoparathyroidism Trial Meets Primary, Secondary Endpoints
Tickers ASND
Tags Benzinga ASND Biotech
From Benzinga
7 Biotech Stocks With Key Catalysts in March
Tickers AKBA AMLX ARNA ASND
Tags TERN Stocks to Buy ARNA
From InvestorPlace
Expert Ratings For Ascendis Pharma
Tickers ASND
Tags Benzinga ASND Market News
From Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
Tickers AMPE ASND ATRS BGNE
Tags IMCR General AMPE
From Benzinga
Earnings Scheduled For March 2, 2022
Tickers AEO AI AMRX ANF
Tags PZA TRMD GPL
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Tickers ACLX ACVA ALNY AMED
Tags PWR SNAP TTD
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
Tickers AGNC ALL ANET ASND
Tags SMRT ZION ANET
From Benzinga
Where Ascendis Pharma Stands With Analysts
Tickers ASND
Tags Analyst Ratings BZI/AAR Market News
From Benzinga
Ascendis Pharma's Growth Hormone Deficiency Med Scores European Approval
Tickers ASND
Tags Health Care General Biotech
From Benzinga
Where Ascendis Pharma Stands With Analysts
Tickers ASND
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
Tickers ADGI ADT AEIS AKAM
Tags GTLB FWRD GOOS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
Tickers ALLE ALLT AMPL APLS
Tags SIVB HZNP APLS
From Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
Tickers ASND BMY CADL CNTB
Tags ENTA BMY General
From Benzinga
Ascendis' Hypoparathyroidism Candidate Shows Durable Benefit At 84 Weeks
Tickers ASND
Tags Health Care General Phase 2 Trial
From Benzinga
10 Biggest Price Target Changes For Monday
Tickers ASND BTAI CARG EVGO
Tags PHUN KRUS Market News
From Benzinga
Analyst Ratings For Ascendis Pharma
Tickers ASND
Tags Benzinga ASND Analyst Ratings
From Benzinga
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Call Transcript
Tickers ASND
Tags Market News ASND Recent Press Releases
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
Tickers AGL APO ARRY ASND
Tags CLW F GATO
From Benzinga
This Growth Hormone Drug Could Be a Boost For Pfizer
Tickers ASND OPK PFE
Tags Market News PFE ASND
From Motley Fool
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
Tickers ADVM ASND BCYC CCXI
Tags IPOs CING TAK
From Benzinga
Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months
Tickers ASND OPK PFE
Tags OPK Movers Growth Hormone
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Tickers ABCL ABSI AFIB ALZN
Tags IBB KTTA Benzinga
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Tickers ADIL ADMA AFMD ALEC
Tags News ISRG ADIL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.